Literature DB >> 19890661

Vascular endothelial growth factor and endoglin expression in colorectal cancer.

Konstantinos Dassoulas1, Maria Gazouli, George Theodoropoulos, Zoi Christoni, Spyros Rizos, Adamantia Zisi-Serbetzoglou, Chrissa Glava, Theodoros Karantanos, Christos Klonaris, Petros Karakitsos.   

Abstract

PURPOSE AND METHODS: Vascular endothelial growth factor (VEGF) overexpression has been associated with advanced stage and poor survival in several cancers. Additionally, endoglin was proposed as a marker of neovascularization in solid malignancies. The aim of this study was to evaluate the association between the VEGF and endoglin expression in colorectal carcinoma patients, as well as to correlate the VEGF and endoglin expression with standard parameters, to define their potential prognostic role. VEGF and endoglin expression were evaluated in 99 unrelated patients with colorectal cancer using immunohistochemistry.
RESULTS: Vascular endothelial growth factor and endoglobin expression were positively interrelated. No significant correlation of VEGF and endoglin expression with clinicopathological parameters was observed in our cases. The Kaplan-Meier survival curves have demonstrated a clear association of cancer-specific overall survival with high VEGF, as well as high endoglin expression.
CONCLUSION: Our results support that VEGF and endoglin act as two valuable indicators of prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890661     DOI: 10.1007/s00432-009-0709-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.

Authors:  A Couvelard; F Paraf; V Gratio; J Y Scoazec; D Hénin; C Degott; J F Fléjou
Journal:  J Pathol       Date:  2000-09       Impact factor: 7.996

2.  Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.

Authors:  Rahmawati Minhajat; Daisuke Mori; Fumio Yamasaki; Yasuo Sugita; Toshimi Satoh; Osamu Tokunaga
Journal:  Virchows Arch       Date:  2005-09-22       Impact factor: 4.064

3.  Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.

Authors:  Pernilla Wikström; Ingela Franck Lissbrant; Pär Stattin; Lars Egevad; Anders Bergh
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

4.  Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.

Authors:  Y Takahashi; S L Tucker; Y Kitadai; A N Koura; C D Bucana; K R Cleary; L M Ellis
Journal:  Arch Surg       Date:  1997-05

5.  Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Authors:  Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

6.  Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.

Authors:  Reda S Saad; Yulin L Liu; Girija Nathan; James Celebrezze; David Medich; Jan F Silverman
Journal:  Mod Pathol       Date:  2004-02       Impact factor: 7.842

Review 7.  CD105 is important for angiogenesis: evidence and potential applications.

Authors:  Sarah E Duff; Chenggang Li; John M Garland; Shant Kumar
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

8.  Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.

Authors:  P Bossi; G Viale; A K Lee; R Alfano; G Coggi; S Bosari
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

9.  Tumor angiogenesis and rectal carcinoma.

Authors:  T J Saclarides; N J Speziale; E Drab; D J Szeluga; D B Rubin
Journal:  Dis Colon Rectum       Date:  1994-09       Impact factor: 4.585

10.  p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.

Authors:  C Fondevila; J P Metges; J Fuster; J J Grau; A Palacín; A Castells; A Volant; M Pera
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  9 in total

1.  Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.

Authors:  Valeria Barresi; Carmela Di Gregorio; Luca Regiani-Bonetti; Maurizio Ponz-De Leon; Gaetano Barresi; Enrica Vitarelli
Journal:  Virchows Arch       Date:  2010-06-08       Impact factor: 4.064

2.  Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer.

Authors:  Meng Wang; Gong-Yan Chen; Hong-Tao Song; Xuan Hong; Zhao-Yang Yang; Guang-Jie Sui
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

3.  Chromatin immunoprecipitation to analyze DNA binding sites of HMGA2.

Authors:  Nina Winter; Rolf Nimzyk; Carolin Bösche; Anke Meyer; Jörn Bullerdiek
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

4.  Impact of PINCH expression on survival in colorectal cancer patients.

Authors:  Jasmine Lööf; Johan Rosell; Charlotte Bratthäll; Siv Doré; Hans Starkhammar; Hong Zhang; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2011-03-22       Impact factor: 4.430

5.  Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis.

Authors:  Zeljko Martinovic; Drazen Kovac; Mia Martinovic
Journal:  Gastroenterol Res Pract       Date:  2015-05-21       Impact factor: 2.260

6.  C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma.

Authors:  Laura Credidio; Carmen Silvia Passos Lima; Raquel Leal; Maria Lourdes S de Ayrizono; João José Fagundes; Luis Alberto Magna; Claudio Saddy Rodrigues Coy
Journal:  BMC Res Notes       Date:  2014-10-31

Review 7.  Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review.

Authors:  Daniel Sur; Andrei Havasi; Cristian Virgil Lungulescu; Simona Ruxandra Volovat; Claudia Burz; Alexandru Irimie
Journal:  Med Pharm Rep       Date:  2022-07-26

8.  ¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer.

Authors:  Ashley M Groves; Manu Shastry; Manuel Rodriguez-Justo; Anmol Malhotra; Raymondo Endozo; Timothy Davidson; Tina Kelleher; Kenneth A Miles; Peter J Ell; Mohammed R Keshtgar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-14       Impact factor: 9.236

9.  Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis.

Authors:  Jinguo Zhang; Lingyun Zhang; Qunbo Lin; Weimin Ren; Guoxiong Xu
Journal:  Oncotarget       Date:  2017-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.